Form 8-K/A date of report 08-12-24 true 0000803578 0000803578 2024-08-12 2024-08-12
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 

 
FORM 8-K/A
(Amendment No. 1)
 

 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): August 12, 2024
 
 

 
FIREFLY NEUROSCIENCE, INC.
(Exact Name of Registrant as Specified in Its Charter)
 
 

 
 
Delaware
 
001-41092
 
54-1167364
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
 
1100 Military Road
Kenmore, NY
 
14217
(Address of principal executive offices)
 
(Zip Code)
 
Registrants telephone number, including area code: 888-237-6412
 
 
(Former name or former address, if changed since last report)
 
 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Common Stock, $0.0001 par value per share
 
AIFF
 
The Nasdaq Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
EXPLANATORY NOTE
 
This Current Report on Form 8-K/A (this “Amendment”) amends the Current Report on Form 8-K of Firefly Neuroscience, Inc. (the “Company”) filed with the U.S. Securities and Exchange Commission on August 12, 2024 (the “Original 8-K”). The purpose of this Amendment is to include the report (the “Report”) of the Company’s independent registered public accounting firm, Turner Stone & Company, LLP, in the Audited Financial Statements of Firefly Neuroscience, Inc. for the year ended December 31, 2023, previously filed as Exhibit 99.1 to the Original 8-K, which such Report was inadvertently excluded from Exhibit 99.1 in the Original 8-K.
 
This Amendment additionally amends and restates the first paragraph in the section entitled “Private Placement” in the Original 8-K with the following:
 
“As previously reported, on July 26, 2024, Firefly entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors, pursuant to which Firefly agreed to issue and sell (i) 3,069,287 shares (the “PIPE Shares”) of Firefly Common Stock, (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 4,849,265 shares of Firefly Common Stock, and (iii) warrants (the “Warrants”) to purchase up to 7,918,552 shares of Firefly Common Stock in a private placement (the “Private Placement”). The purchase price of each PIPE Share and accompanying Warrant was $0.442 and the purchase price of each Pre-Funded Warrant and accompanying Warrant was $0.4419. The Private Placement closed on August 12, 2024, substantially contemporaneous with the consummation of the Merger. The aggregate gross proceeds from the transaction were approximately $3.5 million, before deducting estimated offering expenses payable by the Company.”
 
No other changes have been made to the Original Form 8-K.
 
 

 
Item 9.01
Financial Statements and Exhibits.
 
(d) Exhibits.
 
     
Exhibit
Number
 
Description of Exhibit
   
99.1
 
Audited Financial Statements of Firefly Neuroscience, Inc. for the year ended December 31, 2023
 
104
 
Cover Page Interactive Data File
 
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
    FIREFLY NEUROSCIENCE, INC.  
Date: September 16, 2024
By:
/s/ Jon Olsen
Name
Jon Olsen
Title:
Chief Executive Officer